journal article·2023-02-09Open access

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)

Nityanand Prakash, Jiseong Kim, Jieun Jeon, Siyeon Kim, Yoshie Arai, Alvin Bacero Bello, Hansoo Park, Soo-Hong Lee

Biomaterials Research· Volume 27· Issue 1

Abstract

Abstract The use of mesenchymal stem cells (MSCs) for clinical purposes has skyrocketed in the past decade. Their multilineage differentiation potentials and immunomodulatory properties have facilitated the discovery of therapies for various illnesses. MSCs can be isolated from infant and adult tissue sources, which means they are easily available. However, this raises concerns because of the heterogeneity among the various MSC sources, which limits their effective use. Variabilities arise from donor- and tissue-specific differences, such as age, sex, and tissue source. Moreover, adult-sourced MSCs have limited proliferation potentials, which hinders their long-term therapeutic efficacy. These limitations of adult MSCs have prompted researchers to develop a new method for generating MSCs. Pluripotent stem cells (PSCs), such as embryonic stem cells and induced PSCs (iPSCs), can differentiate into various types of cells. Herein, a thorough review of the characteristics, functions, and clinical importance of MSCs is presented. The existing sources of MSCs, including adult- and infant-based sources, are compared. The most recent techniques for deriving MSCs from iPSCs, with a focus on biomaterial-assisted methods in both two- and three-dimensional culture systems, are listed and elaborated. Finally, several opportunities to develop improved methods for efficiently producing MSCs with the aim of advancing their various clinical applications are described.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, Dongguk University, Seoul 04620, Korea.

School of Integrative Engineering, Chung-Ang University, Seoul 06911, Korea.

Funding

Ministry of Science and ICT, South Korea

References (100+)

Show source-provided references
1. Bianco P Robey PG Simmons PJ. Mesenchymal Stem Cells: Revisiting History Concepts and Assays. Cell Stem Cell. 2008;2(4):313–9.10.1016/j.stem.2008.03.002 ↗
2. Andrzejewska A Lukomska B Janowski M. Concise Review: Mesenchymal Stem Cells: From Roots to Boost. Stem Cells. 2019;37(7):855–64.10.1002/stem.3016 ↗
3. Andrukhov O Behm C Blufstein A Rausch-Fan X. Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: Implication in disease and tissue regeneration. World J Stem Cells. 2019;11(9):604–14.10.4252/wjsc.v11.i9.604 ↗
4. Murphy MB Moncivais K Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45(11):e54.10.1038/emm.2013.94 ↗
5. 10.18295/squmj.2018.18.03.00210.18295/squmj.2018.18.03.002 ↗
6. 10.1080/1465324060085590510.1080/14653240600855905 ↗
7. 10.1002/sctm.18-012210.1002/sctm.18-0122 ↗
8. 10.3390/jcm807102510.3390/jcm8071025 ↗
9. Pankajakshan D Agrawal DK. Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration.J Biomed Technol Res. 2014;1(1).10.19104/jbtr.2014.107 ↗
10. Linero I Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS ONE. 2014 Sep;8(9):e107001.10.1371/journal.pone.0107001 ↗
11. Beane OS Fonseca VC Cooper LL Koren G Darling EM. Impact of aging on the regenerative properties of bone marrow- muscle- and adipose-derived mesenchymal stem/stromal cells. PLoS ONE. 2014 Dec;26(12):e115963.10.1371/journal.pone.0115963 ↗
12. 10.1007/s00264-013-2059-210.1007/s00264-013-2059-2 ↗
13. 10.1016/j.stem.2020.09.01410.1016/j.stem.2020.09.014 ↗
14. 10.1186/s13045-021-01037-x10.1186/s13045-021-01037-x ↗
15. 10.1038/s41536-019-0083-610.1038/s41536-019-0083-6 ↗
16. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393–403. 1:STN:280:DyaE38%2FmsFGmsg%3D%3D
17. 10.1080/1465324050031923410.1080/14653240500319234 ↗
18. Lin CS Xin ZC Dai J Lue TF. Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges. Histol Histopathol. 2013 Sep;28:1109–16.
19. 10.1096/fj.02-0634rev10.1096/fj.02-0634rev ↗
20. 10.3389/fcell.2019.0006610.3389/fcell.2019.00066 ↗
21. 10.1096/fj.05-5460rev10.1096/fj.05-5460rev ↗
22. 10.15283/ijsc.2014.7.2.11810.15283/ijsc.2014.7.2.118 ↗
23. 10.1002/jev2.1206710.1002/jev2.12067 ↗
24. 10.1634/stemcells.2005-034210.1634/stemcells.2005-0342 ↗
25. Salehinejad P, Moshrefi M, Eslaminejad T. An overview on mesenchymal stem cells derived from extraembryonic tissues: supplement sources and isolation methods. Stem Cells Cloning. 2020;13:57–65.
26. 10.3390/ijms1902036010.3390/ijms19020360 ↗
27. 10.1002/stem.138010.1002/stem.1380 ↗
28. 10.1038/cdd.2015.16810.1038/cdd.2015.168 ↗
29. 10.1186/scrt3110.1186/scrt31 ↗
30. 10.1002/pros.2043210.1002/pros.20432 ↗
31. 10.3389/fimmu.2015.0056010.3389/fimmu.2015.00560 ↗
32. 10.1111/cpr.1271210.1111/cpr.12712 ↗
33. 10.1038/nri239510.1038/nri2395 ↗
34. 10.3389/fneur.2018.0046610.3389/fneur.2018.00466 ↗
35. 10.1182/blood.V99.10.383810.1182/blood.V99.10.3838 ↗
36. 10.1126/scitranslmed.300556810.1126/scitranslmed.3005568 ↗
37. 10.3389/fbioe.2020.0004310.3389/fbioe.2020.00043 ↗
38. 10.3389/fcell.2021.63271710.3389/fcell.2021.632717 ↗
39. 10.1111/j.1756-185X.2011.01599.x10.1111/j.1756-185X.2011.01599.x ↗
40. 10.1111/1756-185X.1267010.1111/1756-185X.12670 ↗
41. 10.3727/00000000478398374710.3727/000000004783983747 ↗
42. 10.1097/TP.000000000000016710.1097/TP.0000000000000167 ↗
43. 10.1002/sctm.18-018310.1002/sctm.18-0183 ↗
44. 10.1093/asj/sjv13510.1093/asj/sjv135 ↗
45. 10.5966/sctm.2015-024510.5966/sctm.2015-0245 ↗
46. 10.1186/s13287-019-1248-310.1186/s13287-019-1248-3 ↗
47. Chen YC, Chang CH. Clinical application of mesenchymal stem cells for cartilage regeneration. Plast Aesthet Res. 2020;7:49.
48. 10.1111/j.1600-0501.2010.01981.x10.1111/j.1600-0501.2010.01981.x ↗
49. 10.1016/j.injury.2020.02.07010.1016/j.injury.2020.02.070 ↗
50. 10.1186/s13578-020-00475-310.1186/s13578-020-00475-3 ↗
51. 10.1227/NEU.000000000000105610.1227/NEU.0000000000001056 ↗
52. 10.1016/S0140-6736(08)60690-X10.1016/S0140-6736(08)60690-X ↗
53. 10.1016/j.amjcard.2004.03.03410.1016/j.amjcard.2004.03.034 ↗
54. 10.1007/s10753-007-9025-310.1007/s10753-007-9025-3 ↗
55. 10.1002/sctm.20-015510.1002/sctm.20-0155 ↗
56. 10.1371/journal.pone.016426910.1371/journal.pone.0164269 ↗
57. 10.1002/cyto.a.2324210.1002/cyto.a.23242 ↗
58. 10.1111/j.1365-2184.1987.tb01309.x10.1111/j.1365-2184.1987.tb01309.x ↗
59. Drela K Stanaszek L Snioch K Kuczynska Z Wrobel M Sarzynska S et al. Bone marrow-derived from the human femoral shaft as a new source of mesenchymal stem/stromal cells: an alternative cell material for banking and clinical transplantation.Stem Cell Res Ther. 2020;11.10.1186/s13287-020-01697-5 ↗
60. 10.1155/2020/435635910.1155/2020/4356359 ↗
61. 10.1038/srep2825010.1038/srep28250 ↗
62. 10.1089/10763270130006285910.1089/107632701300062859 ↗
63. 10.3727/096368912X65512710.3727/096368912X655127 ↗
64. 10.1111/and.1389210.1111/and.13892 ↗
65. 10.1186/s13287-021-02265-110.1186/s13287-021-02265-1 ↗
66. 10.1155/2017/285190610.1155/2017/2851906 ↗
67. 10.1155/2016/470957210.1155/2016/4709572 ↗
68. 10.1155/2016/657946310.1155/2016/6579463 ↗
69. 10.1186/ar435510.1186/ar4355 ↗
70. 10.1155/2017/931232910.1155/2017/9312329 ↗
71. Heil JR Bordoni B Embryology. Umbilical Cord. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557490/
72. 10.1007/s12015-011-9289-810.1007/s12015-011-9289-8 ↗
73. 10.1007/s12015-021-10157-310.1007/s12015-021-10157-3 ↗
74. 10.15283/ijsc1803410.15283/ijsc18034 ↗
75. 10.4252/wjsc.v6.i2.19510.4252/wjsc.v6.i2.195 ↗
76. 10.1186/s13287-021-02222-y10.1186/s13287-021-02222-y ↗
77. 10.1007/s00441-017-2699-410.1007/s00441-017-2699-4 ↗
78. 10.1016/j.apjtm.2015.07.02210.1016/j.apjtm.2015.07.022 ↗
79. 10.1038/srep1884410.1038/srep18844 ↗
80. 10.1111/1348-0421.1225910.1111/1348-0421.12259 ↗
81. 10.1111/j.1524-475X.2010.00616.x10.1111/j.1524-475X.2010.00616.x ↗
82. 10.1038/srep1578410.1038/srep15784 ↗
83. 10.1007/s00404-014-3231-710.1007/s00404-014-3231-7 ↗
84. Siddesh SE Gowda DM Jain R Gulati A Patil GS Anudeep TC et al. Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia—a regenerative dogma.Stem Cell Investig [. 2021;8.10.21037/sci-2020-034 ↗
85. 10.1177/0271678X1773196410.1177/0271678X17731964 ↗
86. 10.1186/1471-2121-7-1410.1186/1471-2121-7-14 ↗
87. Yosupov N Haimov H Juodzbalys G Mobilization. Isolation and Characterization of Stem Cells from Peripheral Blood: a Systematic Review.J Oral Maxillofac Res. 2017;8(1).10.5037/jomr.2017.8101 ↗
88. McDaniel JS Antebi B Pilia M Hurtgen BJ Belenkiy S Necsoiu C et al. Quantitative Assessment of Optimal Bone Marrow Site for the Isolation of Porcine Mesenchymal Stem Cells. Stem Cells Int. 2017; 2017:1836960.10.1155/2017/1836960 ↗
89. 10.1186/s13287-018-0876-310.1186/s13287-018-0876-3 ↗
90. 10.1634/stemcells.2005-054610.1634/stemcells.2005-0546 ↗
91. 10.1074/jbc.M111.25652910.1074/jbc.M111.256529 ↗
92. 10.1002/stem.168110.1002/stem.1681 ↗
93. 10.1155/2016/318749110.1155/2016/3187491 ↗
94. 10.3390/ijms16071560910.3390/ijms160715609 ↗
95. 10.1089/ten.tea.2010.034610.1089/ten.tea.2010.0346 ↗
96. 10.1111/jcmm.1275210.1111/jcmm.12752 ↗
97. 10.1371/journal.pone.001565210.1371/journal.pone.0015652 ↗
98. 10.15419/bmrat.v6i4.53810.15419/bmrat.v6i4.538 ↗
99. 10.3389/fbioe.2017.0003210.3389/fbioe.2017.00032 ↗
100. Kan C, Chen L, Hu Y, Lu H, Li Y, Kessler JA, et al. Microenvironmental factors that regulate mesenchymal stem cells: Lessons learned from the study of heterotopic ossification. Histol Histopathol. 2017;32:977–85. 1:CAS:528:DC%2BC1MXhtFOisrw%3D